Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature
- PMID: 21785961
- DOI: 10.1007/s00296-011-2000-1
Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature
Abstract
The treatment of severe and refractory cases of reactive arthritis is not well defined. There is a limited data about the use of tumor necrosis factor-α (TNF-α) blockers in reactive arthritis. Herein is a description of a patient with severe case of Chlamydia trachomatis-related reactive arthritis that was refractory to nonsteroidal anti-inflammatory drugs, sulfasalazine, prednisone, and methotrexate and was successfully treated with etanercept.
Similar articles
-
Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection.Rheumatol Int. 2010 Mar;30(5):679-80. doi: 10.1007/s00296-009-0965-9. Epub 2009 May 23. Rheumatol Int. 2010. PMID: 19466419
-
TNF involvement and anti-TNF therapy of reactive and unclassified arthritis.Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S130-4. Clin Exp Rheumatol. 2002. PMID: 12463463 Review.
-
Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.Joint Bone Spine. 2013 Jul;80(4):426-8. doi: 10.1016/j.jbspin.2013.01.002. Epub 2013 Mar 1. Joint Bone Spine. 2013. PMID: 23453475
-
Acute exacerbation of ankylosing spondylitis after chlamydial infection in a patient well-controlled with etanercept.Int J Rheum Dis. 2012 Oct;15(5):e113-5. doi: 10.1111/j.1756-185X.2012.01748.x. Epub 2012 Apr 29. Int J Rheum Dis. 2012. PMID: 23083043 No abstract available.
-
Spondyloarthropathies in 2010: new insights into therapy-TNF blockade and beyond.Nat Rev Rheumatol. 2011 Feb;7(2):78-80. doi: 10.1038/nrrheum.2010.224. Nat Rev Rheumatol. 2011. PMID: 21289612 Review. No abstract available.
Cited by
-
Use of biologic agents in ocular manifestations of rheumatic disease.Int J Rheumatol. 2012;2012:203819. doi: 10.1155/2012/203819. Epub 2011 Dec 15. Int J Rheumatol. 2012. PMID: 22229035 Free PMC article.
-
Treatment of Reactive Arthritis with Biological Agents.Curr Rheumatol Rep. 2024 Dec;26(12):450-458. doi: 10.1007/s11926-024-01165-6. Epub 2024 Sep 23. Curr Rheumatol Rep. 2024. PMID: 39312088 Review.
-
The role of intracellular organisms in the pathogenesis of inflammatory arthritis.Int J Inflam. 2014;2014:158793. doi: 10.1155/2014/158793. Epub 2014 Jun 5. Int J Inflam. 2014. PMID: 24995143 Free PMC article. Review.
-
Treatment of reactive arthritis with biological agents: a review.Biosci Rep. 2020 Feb 28;40(2):BSR20191927. doi: 10.1042/BSR20191927. Biosci Rep. 2020. PMID: 32039436 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources